Turn Therapeutics Inc.
TTRX
$6.93
$0.111.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.60M | -1.95M | -2.56M | -1.32M | -1.71M |
| Total Depreciation and Amortization | 42.40K | 40.30K | 38.50K | 36.90K | 48.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.10M | -1.84M | 413.70K | 622.90K | 655.20K |
| Change in Net Operating Assets | 1.26M | 1.69M | 786.50K | -446.60K | -378.20K |
| Cash from Operations | -3.80M | -2.46M | -1.72M | -1.50M | -1.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -133.40K | -121.20K | -97.60K | -51.30K | -75.40K |
| Cash from Investing | -149.30K | -153.00K | -129.40K | -83.10K | -91.30K |
| Total Debt Issued | 6.72M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.84M | 4.77M | 2.11M | 1.84M | 2.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.13M | 6.34M | 3.69M | 3.42M | 2.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.19M | 3.74M | 1.86M | 1.85M | 539.60K |